A detailed history of Credit Suisse Ag transactions in Legend Biotech Corp stock. As of the latest transaction made, Credit Suisse Ag holds 117,505 shares of LEGN stock, worth $4.72 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
117,505
Previous 111,304 5.57%
Holding current value
$4.72 Million
Previous $6.7 Million 1.6%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$55.06 - $69.99 $341,427 - $434,007
6,201 Added 5.57%
117,505 $6.59 Million
Q4 2023

Feb 08, 2024

BUY
$57.25 - $69.74 $1.72 Million - $2.09 Million
29,964 Added 36.84%
111,304 $6.7 Million
Q3 2023

Nov 13, 2023

SELL
$63.16 - $76.5 $99,919 - $121,023
-1,582 Reduced 1.91%
81,340 $5.46 Million
Q2 2023

Aug 11, 2023

BUY
$46.28 - $75.01 $425,914 - $690,317
9,203 Added 12.48%
82,922 $5.72 Million
Q1 2023

May 10, 2023

BUY
$43.42 - $57.37 $400,679 - $529,410
9,228 Added 14.31%
73,719 $3.55 Million
Q4 2022

Feb 13, 2023

SELL
$38.8 - $55.46 $197,880 - $282,846
-5,100 Reduced 7.33%
64,491 $3.22 Million
Q3 2022

Nov 10, 2022

SELL
$38.15 - $57.1 $1.77 Million - $2.65 Million
-46,488 Reduced 40.05%
69,591 $2.84 Million
Q2 2022

Aug 12, 2022

SELL
$33.54 - $55.0 $667,412 - $1.09 Million
-19,899 Reduced 14.63%
116,079 $6.39 Million
Q1 2022

May 16, 2022

BUY
$31.02 - $48.18 $811,297 - $1.26 Million
26,154 Added 23.81%
135,978 $4.94 Million
Q4 2021

Feb 14, 2022

BUY
$41.14 - $56.98 $3.83 Million - $5.3 Million
92,981 Added 552.05%
109,824 $5.12 Million
Q3 2021

Nov 12, 2021

BUY
$35.31 - $50.56 $87,074 - $124,680
2,466 Added 17.15%
16,843 $852,000
Q2 2021

Aug 16, 2021

SELL
$25.8 - $41.09 $54,592 - $86,946
-2,116 Reduced 12.83%
14,377 $590,000
Q1 2021

May 14, 2021

BUY
$23.55 - $32.4 $78,138 - $107,503
3,318 Added 25.18%
16,493 $478,000
Q4 2020

Feb 12, 2021

BUY
$25.8 - $32.39 $339,915 - $426,738
13,175 New
13,175 $371,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.